Skip to main content

In the Spotlight: Autoimmune Hepatitis

Today's blog entry is written by our awesome summer intern, Jessica Naftaly.

Since we love spreading awareness about rare diseases, we decided to post an additional rare diseases blog this month. May is hepatitis awareness month! Many assume that the ONLY way to be diagnosed with hepatitis is through drugs, drinking too much alcohol, or having unprotected sexual intercourse. Additionally, it is sometimes assumed that all types of hepatitis are contagious. All of these assumptions are untrue. One type of hepatitis called autoimmune hepatitis (AIH) occurs when the body attacks the liver causing inflammation.

Snapshot: AIH is a chronic autoimmune liver condition in which healthy liver cells are mistaken for being foreign and are attacked. The body attacking itself leads to cirrhosis or inflammation of the liver. Overtime without treatment AIH can cause the need for a liver transplant due to liver failure. Although the cause of AIH is not researched well, other autoimmune diseases, environmental factors, and genetics may play a role in AIH development. Symptoms include jaundice, dark colored urine, fatigue, itching, joint pain, nausea, skin rashes, pain in the upper right quadrant of the abdomen, and light colored stool. There are two types of AIH, type 1 and type 2.

How Common is it?
About 0.1-1.2 per 100,000 Americans have AIH. AIH is more commonly seen in females. The disease can show up at any age but is usually seen in ages 10-20 years old or 45-70 years old.

What About Diagnosis and Treatment?
Blood tests can detect elevated liver enzymes, which could be an indication of inflammation. A liver biopsy is the gold standard for diagnosis. Although AIH is not contagious, if untreated it can lead to serious problems. Treatments include medications such as prednisone, azathioprine, and other types of immunosuppressants such as cellcept. Liver transplants are used for patients who do not respond to medication or are in liver failure.

What is the Social and Emotional Impact?
There is stigma associated with the word hepatitis. Some patients with AIH do not disclose their illness for fear of being discriminated. Instead of saying “I have AIH” many prefer to say “I have a liver disease.” Patients who take prednisone may face emotional mood swings, swelling in the face, weight gain, and sleep disturbances that can contribute to difficulty adjusting emotionally and socially. Yellowing of the skin/eyes and uncontrollable itching due to jaundice can make social interactions complex taking a toll on patients emotionally. There is limited research on the social and emotional impact on AIH patients. A study from Yale University School of Medicine, however, found that psychological stress correlated with AIH patients who relapsed.

Helpful Resources
American Liver Foundation
National Digestive Diseases Information Clearinghouse

Popular posts from this blog

Game of Crohn's

There are 2 days left in 2017 and I've considered writing this blog post for most of the previous 363.  It's on a topic that nobody wants to talk about. Ever.

Let me start by saying Crohn's disease is a stigmatized disease.  A recent study found it's more stigmatized than HIV/AIDS and genital herpes among the general public.  And this topic, I think, takes that stigma and multiplies it by about 8.

Most people who know anything about IBD know it involves a few main issues:  diarrhea, abdominal pain, and sometimes blood in said diarrhea.  Because Crohn's is a giving disease, it also comes with a slew of other problems including joint pains, eye inflammation, skin inflammation, bone density loss, mind-numbing fatigue, and fuzzy toenails.

Ok maybe not that last one. 

Around 1/3 of us develop "fistulizing disease."  Or what I like to call body termites.  Fistulas aren't unique to IBD and can happen for other reasons, but IBD is a main source of the fistula…

The Long Shot

I don't even know where to begin as my head is still spinning with the news I received today.  So I'm just going to put it out into the ether:

Entyvio (vedolizumab), which I started for my Crohn's disease about 6 months ago, did what no other approach has:  cleared my eosinophilic esophagitis. 

But wait, isn't Entyvio a drug for inflammatory bowel disease?  Yes.

Is Eosinophilic Esophagitis a type of inflammatory bowel disease?  Nope.

Are IBD and EoE related at all?  As far as we know today, no.  There are very few overlapping cases.

So WTF happened?

Without getting into the biomechanics of a drug that's way over my pay grade in medical understanding, my gastroenterologist had a theory that the way Entyvio works would block the cascade of eosinophils (a part of your immune system, a type of white blood cell) through it's magical way of selectively keeping my immune system from attacking my digestive tract.

She was fucking right.

Since being diagnosed with EoE in ear…


I've been thinking a lot about how we live in an era of infinite access to infinite information (thanks, internet tubes!) yet we still fall into many of the well-established psychological laws, if we can call them that, of human behavior.  Don't worry, this isn't going to be some drawn out post on social psychology. Wikipedia is great for that.

I want to talk about bubbles.  Information bubbles, that is. And how each one of us lives in one to some extent, no matter how educated or enlightened we see ourselves to be. And even if we know we live in said bubble, it takes being shown information that directly conflicts with how you think things are, or should be, and the result is you feel kinda ew - the technical term for "ew" being cognitive dissonance.

I live in a bubble.

In my bubble is the world of academic medicine, academic health psychology, and a circle of psychologists dedicated to people living with chronic digestive illness.  I live in Chicago, a major me…